Clinical Trials on Gingivitis; Chronic in Australia

Total 1351 results

Schülke & Mayr GmbH

Completed

Study to Assess the Inhibition of Plaque Formation in Subjects With a Gingival Index ≤1.5

Inhibition of Plaque Formation (by Gingivitis-Index ≤1.5)

Austria, Germany
The Canberra Hospital

Completed

Intravenous Saline Pre-hydration in Patients Undergoing Outpatient Colonoscopy

Colonic Diseases

Australia
Oslo University Hospital
St John of God Hospital, Vienna; Nepean Blue Mountains Local Health District

Completed

Bowel ENDOmetriosis; Evaluation of Diagnostics and Quality of Life (ENDO)

Quality of Life | Pain, Chronic | Deep Endometriosis | Bowel Dysfunction | Endometriosis Related Pain | Endometriosis Rectum | Deep Infiltrating Endometriosis

Norway, Australia, Austria
Novartis Pharmaceuticals

Terminated

Study to Assess Efficacy and Safety of Nilotinib 300mg Twice Daily in Patients With Philadelphia Positive Chronic Myeloid Leukaemia (CML) in Chronic Phase Who Are Intolerant to Prior Tyrosine Kinase Inhibitors. (ENESTswift)

Philidelphia Positive Chronic Myeloid Leukaemia

Australia
Vaxine Pty Ltd
Australian Respiratory and Sleep Medicine Institute

Not yet recruiting

A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection (HBV003)

Chronic Hepatitis b

Australia
Royal Perth Hospital
ReCor Medical, Inc.

Recruiting

REducing Sympathetic Activity Through Ultrasound-based Renal deneRvation in Excessive Cardiovascular Risk populaTions. (RESURRECT)

Heart Failure | Chronic Kidney Diseases | End Stage Renal Disease

Australia
The University of Queensland
Isopogen; Cell and Tissue Therapies

Completed

Trial of Bone-marrow Derived Mesenchymal Stromal Cells (MSC) for New Onset Chronic Lung Allograft Dysfunction (ASSIST-CLAD)

Chronic Lung Allograft Dysfunction (CLAD)

Australia
Australasian Leukaemia and Lymphoma Group
Merck Sharp & Dohme LLC; Novartis Pharmaceuticals

Unknown

Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid Leukaemia (PInNACLe)

Chronic Myeloid Leukaemia

Australia
AdAlta Limited

Completed

Safety, Tolerability, PK and PD Study of AD-214 Administered to Healthy Volunteers and Patients With Interstitial Lung Disease or Chronic Kidney Disease

Chronic Kidney Diseases | Interstitial Lung Disease

Australia
Sir Charles Gairdner Hospital

Completed

Audit of the Effect of Changing From IV to SC Administration of ESA's in Haemodialysis Patients

Anemia | Kidney Failure, Chronic

Australia
TetraLogic Pharmaceuticals

Terminated

Phase I Safety and Tolerability Study of Birinapant in Chronic Hepatitis B

Hepatitis B

Australia
Flinders University

Completed

Breathlessness Exertion and Morphine Sulphate (BEAMS)

Chronic Obstructive Pulmonary Disease | Dyspnea

Australia, New Zealand
Presidio Medical, Inc

Recruiting

Ultra Low Frequency Spinal Cord Stimulation for Chronic Low Back Pain

Chronic Pain | Chronic Low-back Pain

Australia
Sir Charles Gairdner Hospital

Completed

Effect of 25-hydroxyvitamin D and a Structured Exercise Program on Dialysis Patients

End Stage Kidney Disease

Australia
Sir Charles Gairdner Hospital

Completed

Short Term Effects of FX Dialysers on QOL and Inflammation

Kidney Failure, Chronic

Australia
AzurRx SAS

Completed

A Phase IIa Study With Escalating Dose of MS1819-SD

Chronic Pancreatitis | Distal Pancreatectomy

Australia, New Zealand, France
Medical University Innsbruck

Completed

Plaque Reduction Sesame Oil

Gingivitis | Dental Plaque | Oral Microbial Colonization

Austria
Enyo Pharma
CPR Pharma Services Pty Ltd, Australia

Completed

Drug Drug Interaction Study for EYP001 With Entecavir

Hepatitis B, Chronic

Australia
St Vincent's Hospital Melbourne
National Health and Medical Research Council, Australia

Unknown

Determinants of Virological Response After Discontinuation of Nucleoside Analogue Therapy in Hepatitis B Patients (STOP)

Chronic Hepatitis B.

Australia
PathWest Laboratory Medicine WA

Completed

Nasal Tea Tree Oil for the Prevention of Infections in PD Patients

End Stage Renal Failure on Dialysis

Australia
Yangshengtang Co., Ltd
Syneos Health

Completed

Phase 1 Study of 162, a Novel Neutralizing Antibody Targeting Hepatitis B Surface Antigen, in Healthy Adult Subjects

Chronic Hepatitis B

Australia
KDL Inc.

Unknown

A Dose Escalation Study of VS-505 in End Stage Renal Disease Patients Undergoing Hemodialysis

End Stage Renal Disease | Hyperphosphatemia

Australia
Telethon Kids Institute

Recruiting

A Longitudinal Study Looking at the Prevalence, Risk Factors & Consequences of Persistent Post-surgical Pain in Children (POPSICLE)

Chronic Pain

Australia
Arrowhead Pharmaceuticals

Withdrawn

Study of ARC-520 in Patient With Chronic Hepatitis B Virus

Chronic Hepatitis B

Australia
Bristol-Myers Squibb

Withdrawn

Multiple Ascending Dose Study of BMS-929075 in Hepatitis C Virus (HCV) Infected Patients

Chronic Hepatitis C

Australia
Western Health, Australia

Completed

Study of the Effect of Synchronised Anaemia Management in Chronic Kidney Disease (EMAN-Anaemia)

Anemia | Kidney Failure, Chronic

Australia
Kirby Institute
Merck Sharp & Dohme LLC; The University of New South Wales

Completed

Surveillance for Antiviral Resistant Variants in Chronic Hepatitis C Patients (SEARCH-C)

Chronic Hepatitis C Infection

Australia
InnoVein

Recruiting

Feasibility of the InnoVein Valve and Delivery System for Chronic Venous Insufficiency

Chronic Venous Insufficiency

Australia
The University of Queensland

Unknown

Inspiratory Muscle Training in Patients With End Stage Renal Failure

Renal Failure | Chronic Renal Insufficiency

Australia
Gilead Sciences

Completed

CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study (CHARM)

Chronic Hepatitis B

Australia
Saluda Medical Pty Ltd

Recruiting

Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain (Freshwater)

Chronic Pain

Australia
University of South Australia

Completed

Hypnotic Intervention for Women With Chronic Pelvic Pain

Chronic Pain | Pelvic Pain | Psychological | Hypnosis, Animal

Australia
Kirby Institute

Recruiting

Real World Assessment of People Living With Chronic Hepatitis B in Australia (REACH-B)

Hepatitis B

Australia
Stuart Mazzone
Melbourne Health; Merck Sharp & Dohme LLC; Monash University

Recruiting

Effect of Gefapixant on Cough-related Brain Activity in Patients With Chronic Cough

Chronic Cough

Australia
The University of Queensland
University of California, San Diego; University of Sydney

Completed

How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Pain Sample)

Pain, Chronic | Pain, Intractable

Australia
Medtronic Cardiac Rhythm and Heart Failure

Terminated

Reveal LINQ™ Evaluation of Fluid (REEF)

End Stage Renal Disease

Australia
Macfarlane Burnet Institute for Medical Research...
National Health and Medical Research Council, Australia; Gilead Sciences; The... and other collaborators

Recruiting

Eliminate Hepatitis C/EC Partnership Evaluation Protocol

Hepatitis C | Hepatitis C, Chronic | Chronic Hepatitis c

Australia
Bayside Health
University of Adelaide

Unknown

Pharmacogenomics of Interferon and Ribavirin Treatment in Patients With Chronic Hepatitis C Virus Infection

Hepatitis C

Australia
University of Adelaide

Unknown

The Progression From Dysmenorrhoea to Chronic Pelvic Pain

Chronic Pain | Pelvic Pain | Dysmenorrhoea

Australia
GlaxoSmithKline

Completed

A Phase 1, Randomized, Placebo-Controlled, Ascending Cohort, Dose Escalation Study in Normal Healthy Volunteers

Irritable Bowel Syndrome

Australia
GlaxoSmithKline

Completed

A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Volunteers

Irritable Bowel Syndrome

Australia
GlaxoSmithKline

Completed

A Phase I, Randomized, Placebo-controlled, Double Blind, Repeat Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Gastrointestinal Transit Time and Pharmacodynamic Biomarkers of GSK3179106 in Normal Subjects

Irritable Bowel Syndrome

Australia
Bayside Health
Newcastle University; Austin Health

Completed

Effect of Exercise Training on Salivary Immunoglobulin A in Patients With Chronic Obstructive Pulmonary Disease

COPD

Australia
Alios Biopharma Inc.
Vertex Pharmaceuticals Incorporated

Terminated

First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

Hepatitis C, Chronic

Australia, New Zealand
Uptake Medical Corp

Completed

Bronchoscopic Thermal Vapor Ablation (BTVA) for Lung Volume Reduction (BTVA)

Chronic Obstructive Pulmonary Disease | Emphysema

Germany, Ireland, Australia, Austria
Royal Hobart Hospital

Unknown

A Randomised, Blinded Study on Laparoscopic Mesh Reinforcement for Chronic Groin Pain

Chronic Groin Pain

Australia
Stanford University

Completed

Internet Chronic Disease Self-Management Program for Australia

Chronic Disease

United States, Australia
Kirby Institute
Janssen-Cilag Ltd.

Completed

DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C) (DARE-C)

Hepatitis C, Chronic

Australia
Uptake Medical Corp

Completed

Sequential Segmental Treatment of Emphysema With Upper Lobe Predominance (STEP-UP) Study

Emphysema

Australia, Ireland, Germany, Austria, New Zealand, United Kingdom
Bristol-Myers Squibb

Terminated

Evaluation of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children With Chronic Hepatitis C (CHC) Infection

Hepatitis C | Chronic Hepatitis

Australia, Spain

Clinical Trials on Gingivitis; Chronic in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations